Introduction

Montelukast sodium
Montelukast sodium (MTK) is chemically (R-(E))-1-(((1-(3-(2-(7-chloro-2-quinolinyl) ethenyl)phenyl)-3(2-(1-hydroxymethylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid, monosodium salt. [ Fig. 1(a) ]. Montelukast sodium primarily used for the treatment of asthma in children and adults. It is a potent selective inhibitor of leukotriene D4 (LTD4) at the cysteinyl leukotriene receptor cysLT1. Only a few methods viz, HPLC [1, 2] and spectrofluorimetry [3] ,electrophoresis [4] , UV-visiblespectrophotometry [5, 6] LC-MSI-MS [7] and spectrophotometry [8, 9] appeared in the literature for the determination of MTK in bulk and pharmaceutical formulations.
Prasugrel
Prasugrel (PRL) chemically is 5-[2-cyclopropyl-1-(2-fluoro-phenyl)-2-oxoethyl]-4,5,6,7-tetra hydrothieno [3,2-c] pyridin-2-yl acetate Figure-2. It is a member of the thienopyridine class of ADP receptor inhibitors, like ticlopidine and clopidogrel [ Fig. 1(b) ]. These agents reduce the aggregation ("clumping") of platelets by irreversibly binding to P2Y12 receptors. Prasugrel inhibits adenosine diphosphate-induced platelet aggregation more rapidly, more consistently, and to a greater extent than do standard and higher doses of clopidogrel in healthy volunteers and in patients with coronary artery disease. A pharmacodynamic study suggests that acute coronary syndrome (ACS) patients can be safely switched from clopidogrel to prasugrel and that doing so results in a further reduction in platelet function after one week. When patients receive a loading dose of prasugrel prior to switching from clopidogrel, the reduction in platelet function occurs within two hours. Literature survey revealed that some analytical methods like LC-MS [10, 11] and HPTLC [12] have been reported for the estimation of Prasugrel but no spectrophotometric method was reported.
Ondensetron
Ondansetron hydrochloride (OND) is chemically 1,2,3,4-tetrahydro-9-methyl-3-(2-methylimidazol-1-yl methyl) carbazol-4-one hydrochloride is a selective 5HT3 receptor antagonist [ Fig. 1(c) ]. A survey of literature revealed spectrophotometric [13, 14] methods and HPLC [15, 16] methods for the estimation of drug.
Rosuvastatin calcium
Rosuvastatin (ROC), bis ((E)-7-(4-(4-flurophenyl)-6-1sopropyl-2-(methyl (methylsulfonyl) amino) pyr midin-5yl)(3R,5S)-3,5-dihydroxyhept-6-enoic acid) calcium salt is a highly effective 3-hydroxyl-3-methylglutar yl coenzyme A(HMG-CoA) reductase inhibitor. It is widely used for the treatment of hyperlipidemia[ Fig.1(d) ]. I n clinicaltrials, rosuvastatin achieved marked reductions in serum levels of LDL cholesterol, accompanied by m odest increases in HDL Cholesterol and reductions in triglyceride [17, 18] .It may also be used in patients with ho mozygous familial hypercholesterolaemia. Rosuvastatin is given orally as the calcium salt, although the doses ar e expressed in terms of the base. A literature survey reveals that only few methods have been reported for the de termination of RC in pharmaceutical formulation and biological samples including HPCL [19, 20] spectrophotom etry [21] and capillary electrophoresis [22] .
Amlodipine besylate
Arnlodipine besylate (ADB) is a calcium channel blocking agent with vasodilators activity similar to that of nifedipine. It is mainly used for its antiarrhythmic, antianginal and antihypertensive activity (Heynen,). It is chemically known as 2-[(2-aminoethoxy)methyl]-4-(2-chloroprienyl)-1,4-dihydro-6-methyl-3,5pyridinedicarboxylicacid,3ethyl,5methylesterbesylate. B.P describes a reversed phase high performance liquid chromatographic (RP-HPLC) [23] method for the determination of ADB in bulk and pharmaceutical formulations[ Fig. 1(e) ]. The literature survey reveals numbers of methods are reported for the quantitative determination of ADB alone or in combination with other anti hypertensive drugs including spectroscopic and chromatographic methods [24, 25, 26] . Therefore an attempt was made to develop a simple spectrophotometric method for the estimation of above mentioned drugs in pharmaceutical formulations.
Figure-1 (e) Amlodepine besylate
II. Experimental
Reagents and Standards
The pharmaceutical grade drugs were supplied by Arabindo pharmaceuticals and Hetero drugs Pvt Ltd Hyderabad. Rhodamine-B, NBS, and HCl were purchased from S.D.Fine chem Pvt. Ltd., Mumbai, India. Whatman filter paper no.42 was used for filtration purpose. All the reagents used were of AR grade and double distilled water was used throughout the investigation. Tablets were purchased from the local market.
Instrumentation and Optical Characteristics
All absorbance measurements were recorded on Shimadzu 140 double beam spectrophotometer as well as on Thermo Nicolet 100 & Elico 159 UV-Visible single beam spectrophotometers using matched pair of Quartz cells of 10mm path length. A high precision Analytical balance was used for weighing the reagents.
Preparation of standard stock solution
NBS (0.0099M) stock solution was prepared by dissolving 0.1779gm of sample in 100ml standard flask with double distilled water. Rhodamine-B (0.001M) solution was prepared by dissolving 50mg in 100ml standard flask with double distilled water. Stock solutions of both NBS and Rhodamine-B were further diluted to the concentrations of 70 µg mL -1 and 50 µg mL -1 respectively. Standard stock solutions of drugs were prepared by dissolving accurately weighed 40 mg drug to separate 100ml volumetric flasks. The stock solutions of MTK, PRL, OND, ROC and ADB were further diluted with the same solvent to obtain working concentrations. Concentrated HCl was diluted appropriately with double distilled water to get 1M acid solution.
Assay procedure
Aliquots of pure drug solution (1 to 7 mL) were transferred into a series of 10 mL calibrated flask. To each flask, 1 mL of 1 m L -1 hydrochloric acid was added, followed by 1 mL of NBS solution (70 µg mL -1 ). The contents were mixed and the flasks were set aside for 10 min under occasional shaking. Finally, 1 mL of Rhodamine-B solution (50 µg mL -1 ) was added to each flask, diluted to the mark with water and the absorbance of solution was measured at 557 nm against a reagent blank after 10 min. The calibration curve was plotted by taking concentration (µg mL -1 ) of the drugs in X-axis and absorbance in Y-axis.
Tablet analysis
Tablets of respective drug (MTK, PRL, OND, ROC, and ADB) were weighed and powdered. The average weight was calculated. The powder equivalent to 10mg were weighed accurately and made solution to 100ml with double distilled water to produce 100 µg mL -1 of each drug solution. The solutions were sonicated for 15min and filtered through whatmann filter paper No.42. The filtrate was further diluted to get working concentrations and absorbance was measured at 557 nm. The calibration curve was used to calculate the drug from tablets.
III. Validation
Validation is a process of establishing documented evidence, which provides a high degree of assurance that a specific activity will consistently produce a desired result or product meeting its predetermined specifications and quality characteristics. The method was validated for different parameters like Linearity, Accuracy and Precision.
Analytical characteristics 3.1.1. Linearity
The linearity of an analytical method is its ability to elicit test results that are directly or by a welldefined mathematical transformation proportional to the concentration of analyte in samples within a given range. The range of analytical method can be obtained from the linearity, precision and accuracy data. Results should be expressed in terms of correlation co-efficient.
Accuracy (٪recovery)
Accuracy of an analysis is determined by systemic error involved. It is defined as closeness of agreement between the actual (true) value and analytical value and obtained by applying test method for a number of times. Accuracy may often be expressed as ٪Recovery by the assay of added amount of analyte. It is measure of the exactness of the analytical method.
Precision
The reproducibility of the proposed method was determined by performing tablet assay at different time intervals on same (intra-day precision) and on three different days (inter-day precision). Results of intraday precision are expressed in ٪ RSD (Table-3 ).
Results and discussions
The calibration curves for MTK, PRL, OND, ROC and ADB over a concentration range of 1.2-8.4µg mL -1 , 0.6-4.2µg mL -1 , 0.4-2.8µg mL -1 , 0.2-1.4µg mL -1 and 0.1-0.7µg mL -1 were plotted and molar absorptivity for drugs were calculated at the wavelength of 557nm. The regression characteristics are reported in Table- 1. The result of assay is reported in Table- 2. The percent recovery from commercial formulation was shown in table-3. The accuracy of the proposed method was evaluated by percentage recovery studies of the drugs. The %RSD was also less than 2%, for intra-day determinations showing high degree of precision of the proposed method. The results of the method lie within the prescribed limit, showing that method is free from interference from excipients.
IV. Conclusion
The obtained results from the method for the determination of above mentioned drugs indicates that method is novel, simple, accurate and precise. The method is economical compared to other sophisticated analytical instruments. Hence can be used for routine analysis of commercially available formulations. The method is suitable for the determination of these drugs in tablet formulation without interference from commonly used excipients. The solvent used for the method are inexpensive and simple to prepare, and could be used in a quality control laboratory for routine drug analysis. 
